메뉴 건너뛰기




Volumn 18, Issue 2, 2008, Pages 109-118

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis

Author keywords

AA amyloidosis; Rheumatoid arthritis; SAA; SAA1.3 allele

Indexed keywords

AMYLOID A PROTEIN; CODEINE PHOSPHATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPRODISATE; ETANERCEPT; INTERLEUKIN 6 ANTIBODY; LACTIC ACID; METHOTREXATE; OCTREOTIDE; PROTEIN DERIVATIVE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

EID: 41849127766     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-008-0035-2     Document Type: Review
Times cited : (44)

References (92)
  • 1
    • 0142106750 scopus 로고    scopus 로고
    • Amyloidosis
    • In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, editors. 4th ed. Oxford: Oxford University Press
    • Pepys MB, Hawkins PN. Amyloidosis. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr, editors. Oxford textbook of medicine. 4th ed. Oxford: Oxford University Press; 2003. p. 162-73.
    • (2003) Oxford Textbook of Medicine , pp. 162-173
    • Pepys, M.B.1    Hawkins, P.N.2
  • 3
    • 0035164775 scopus 로고    scopus 로고
    • Amyloid precursors and amyloidosis in inflammatory arthritis
    • Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol. 2001;13:67-73.
    • (2001) Curr Opin Rheumatol. , vol.13 , pp. 67-73
    • Cunnane, G.1
  • 4
    • 4544232356 scopus 로고    scopus 로고
    • The effect of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis
    • Sandhu V, Allen SC. The effect of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Pract. 2004;58:740-5.
    • (2004) Int J Clin Pract. , vol.58 , pp. 740-745
    • Sandhu, V.1    Allen, S.C.2
  • 5
    • 33746653708 scopus 로고    scopus 로고
    • Extra-articular manifestations of rheumatoid arthritis: Results of a university hospital of 526 patients in Turkey
    • Calguneri M, Ureten K, Akif Ozturk M, Onat AM, Ertenli I, Kiraz S, et al. Extra-articular manifestations of rheumatoid arthritis: Results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol. 2006;24:305-8.
    • (2006) Clin Exp Rheumatol. , vol.24 , pp. 305-308
    • Calguneri, M.1    Ureten, K.2    Akif Ozturk, M.3    Onat, A.M.4    Ertenli, I.5    Kiraz, S.6
  • 6
    • 33748990076 scopus 로고    scopus 로고
    • The heart and cardiovascular manifestations in rheumatoid arthritis
    • Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology. 2006;45:iV4-7.
    • (2006) Rheumatology , vol.45
    • Voskuyl, A.E.1
  • 7
    • 0033385463 scopus 로고    scopus 로고
    • Amyloid precursors and amyloidosis in rheumatoid arthritis
    • Cunnane G, Whitehead AS. Amyloid precursors and amyloidosis in rheumatoid arthritis. Bailliere's Clin Rheumatol. 1999;13:615-28.
    • (1999) Bailliere's Clin Rheumatol. , vol.13 , pp. 615-628
    • Cunnane, G.1    Whitehead, A.S.2
  • 8
    • 0025936525 scopus 로고
    • Secondary systemic amyloidosis: Response and survival in 64 patients
    • Gertz MA, Kyle RA. Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine. 1991;70:246-56.
    • (1991) Medicine , vol.70 , pp. 246-256
    • Gertz, M.A.1    Kyle, R.A.2
  • 9
    • 0033042001 scopus 로고    scopus 로고
    • Generalized AA-amyloidosis in a 58-year-old Caucasian women with an 18-month history of gastrointestinal tuberculosis
    • Rocken C, Radum D, Glasbrenner B, Malfertheiner P, Roessner A. Generalized AA-amyloidosis in a 58-year-old Caucasian women with an 18-month history of gastrointestinal tuberculosis. Virchows Arch. 1999;434:95-100.
    • (1999) Virchows Arch. , vol.434 , pp. 95-100
    • Rocken, C.1    Radum, D.2    Glasbrenner, B.3    Malfertheiner, P.4    Roessner, A.5
  • 10
    • 84981220132 scopus 로고    scopus 로고
    • Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis
    • Nakamura T, Baba S, Yamamura Y, Tsuruta T, Matsubara S, Tomoda K, et al. Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis. Mod Rheumatol. 2000;10:160-4.
    • (2000) Mod Rheumatol. , vol.10 , pp. 160-164
    • Nakamura, T.1    Baba, S.2    Yamamura, Y.3    Tsuruta, T.4    Matsubara, S.5    Tomoda, K.6
  • 11
    • 0028011380 scopus 로고
    • Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
    • Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid. 1994;1:119-37.
    • (1994) Amyloid. , vol.1 , pp. 119-137
    • Husby, G.1    Marhaug, G.2    Dowton, B.3    Sletten, K.4    Sipe, J.D.5
  • 12
    • 84959744262 scopus 로고
    • The validity of surrogate markers in rheumatic disease
    • Emery P, Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol. 1993;32(Suppl 3):3-8.
    • (1993) Br J Rheumatol. , vol.32 , Issue.SUPPL. 3 , pp. 3-8
    • Emery, P.1    Luqmani, R.2
  • 14
    • 0036176146 scopus 로고    scopus 로고
    • Pathology, diagnosis and pathogenesis of AA amyloidosis
    • Rocken C, Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch. 2002;440:111-22.
    • (2002) Virchows Arch. , vol.440 , pp. 111-122
    • Rocken, C.1    Shakespeare, A.2
  • 15
    • 34548329106 scopus 로고    scopus 로고
    • Amyloid A amyloidosis secondary to rheumatoid arthritis: An uncommon yet important complication
    • Nakamura T. Amyloid A amyloidosis secondary to rheumatoid arthritis: An uncommon yet important complication. Curr Rheumatol Rev. 2007;3:231-41.
    • (2007) Curr Rheumatol Rev. , vol.3 , pp. 231-241
    • Nakamura, T.1
  • 16
    • 0027424029 scopus 로고
    • Serum amyloid A (SAA): An acute phase protein and apolipoprotein
    • Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): An acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131-46.
    • (1993) Atherosclerosis , vol.102 , pp. 131-146
    • Malle, E.1    Steinmetz, A.2    Raynes, J.G.3
  • 17
    • 0033569982 scopus 로고    scopus 로고
    • Serum amyloid A, the major vertebrate acute-phase reactant
    • Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501-23.
    • (1999) Eur J Biochem. , vol.265 , pp. 501-523
    • Uhlar, C.M.1    Whitehead, A.S.2
  • 18
    • 0032844668 scopus 로고    scopus 로고
    • Serum amyloid A1 alleles and plasma concentrations of serum amyloid A
    • Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. Amyloid. 1999;6:199-204.
    • (1999) Amyloid , vol.6 , pp. 199-204
    • Yamada, T.1    Wada, A.2    Itoh, Y.3    Itoh, K.4
  • 19
    • 0026447176 scopus 로고
    • Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis
    • Baba S, Takahashi T, Kasama T, Shirasawa H. Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim Biophys Acta. 1992;1180:195-200.
    • (1992) Biochim Biophys Acta , vol.1180 , pp. 195-200
    • Baba, S.1    Takahashi, T.2    Kasama, T.3    Shirasawa, H.4
  • 20
    • 0027191307 scopus 로고
    • A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57
    • Baba S, Takahashi T, Kasama T, Fujie M, Shirasawa H. A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57. Arch Biochem Biophys. 1993;303:361-6.
    • (1993) Arch Biochem Biophys. , vol.303 , pp. 361-366
    • Baba, S.1    Takahashi, T.2    Kasama, T.3    Fujie, M.4    Shirasawa, H.5
  • 21
    • 29444431739 scopus 로고    scopus 로고
    • Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
    • Xu Y, Yamada T, Satoh T, Okuda Y. Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA. Clin Chem Lab Med. 2006;44:59-63.
    • (2006) Clin Chem Lab Med. , vol.44 , pp. 59-63
    • Xu, Y.1    Yamada, T.2    Satoh, T.3    Okuda, Y.4
  • 22
    • 0029071613 scopus 로고
    • A novel allelic variant of serum amyloid A, SAA1γ: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis
    • Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, et al. A novel allelic variant of serum amyloid A, SAA1γ: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet. 1995;4:1083-7.
    • (1995) Hum Mol Genet. , vol.4 , pp. 1083-1087
    • Baba, S.1    Masago, S.A.2    Takahashi, T.3    Kasama, T.4    Sugimura, H.5    Tsugane, S.6
  • 23
    • 0032855777 scopus 로고    scopus 로고
    • Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis
    • Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, et al. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet. 1999;105:360-6.
    • (1999) Hum Genet. , vol.105 , pp. 360-366
    • Moriguchi, M.1    Terai, C.2    Koseki, Y.3    Uesato, M.4    Nakajima, A.5    Inada, S.6
  • 25
    • 0037367955 scopus 로고    scopus 로고
    • An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians
    • Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, et al. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid. 2003;10:7-11.
    • (2003) Amyloid , vol.10 , pp. 7-11
    • Yamada, T.1    Okuda, Y.2    Takasugi, K.3    Wang, L.4    Marks, D.5    Benson, M.D.6
  • 26
    • 21244461521 scopus 로고    scopus 로고
    • Relative transcriptional activities of SAA1 promoters polymorphic at position -13T(T/C): Potential association between increased transcription and amyloidosis
    • Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, et al. Relative transcriptional activities of SAA1 promoters polymorphic at position -13T(T/C): Potential association between increased transcription and amyloidosis. Amyloid. 2005;12:26-32.
    • (2005) Amyloid , vol.12 , pp. 26-32
    • Moriguchi, M.1    Kaneko, H.2    Terai, C.3    Koseki, Y.4    Kajiyama, H.5    Inada, S.6
  • 27
    • 33750075733 scopus 로고    scopus 로고
    • SAA1 gene polymorphisms and the risk of AA amyloidosis on Japanese patients with rheumatoid arthritis
    • Ajiro J, Narita I, Sato S, Saga D, Hasagawa H, Kuroda T, et al. SAA1 gene polymorphisms and the risk of AA amyloidosis on Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2006;16:294-9.
    • (2006) Mod Rheumatol. , vol.16 , pp. 294-299
    • Ajiro, J.1    Narita, I.2    Sato, S.3    Saga, D.4    Hasagawa, H.5    Kuroda, T.6
  • 28
    • 0036305051 scopus 로고    scopus 로고
    • Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis
    • Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum. 2002;31:355-60.
    • (2002) Semin Arthritis Rheum. , vol.31 , pp. 355-360
    • Gonzalez-Gay, M.A.1    Garcia-Porrua, C.2    Hajeer, A.H.3
  • 29
    • 0036743993 scopus 로고    scopus 로고
    • HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment bias
    • Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment bias. Arthritis Rheum. 2002;46:2320-9.
    • (2002) Arthritis Rheum. , vol.46 , pp. 2320-2329
    • Fries, J.F.1    Wolfe, F.2    Apple, R.3    Erlich, H.4    Bugawan, T.5    Holmes, T.6
  • 30
    • 5644264892 scopus 로고    scopus 로고
    • Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?
    • Turesson C, Weyand CM, Matteson EL. Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations? Arthritis Rheum. 2004;51:853-63.
    • (2004) Arthritis Rheum. , vol.51 , pp. 853-863
    • Turesson, C.1    Weyand, C.M.2    Matteson, E.L.3
  • 31
    • 0031944070 scopus 로고    scopus 로고
    • An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1*0405 in Japanese patients
    • Wakitani S, Imoto K, Murata N, Oonishi H, Ochi T, Yoneda M. An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1*0405 in Japanese patients. Scand J Rheumatol. 1998;27:146-8.
    • (1998) Scand J Rheumatol. , vol.27 , pp. 146-148
    • Wakitani, S.1    Imoto, K.2    Murata, N.3    Oonishi, H.4    Ochi, T.5    Yoneda, M.6
  • 32
    • 0028907841 scopus 로고
    • Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
    • Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995;95:2120-6.
    • (1995) J Clin Invest. , vol.95 , pp. 2120-2126
    • Weyand, C.M.1    McCarthy, T.G.2    Goronzy, J.J.3
  • 35
    • 41849114209 scopus 로고    scopus 로고
    • Effect of SAA1.3 allele genotype on clinical course in Japanese amyloidotic patients secondary to rheumatoid arthritis
    • Nakamura T, Tsukano M, Tomoda K, Yamamura Y, Shono M, Baba S. Effect of SAA1.3 allele genotype on clinical course in Japanese amyloidotic patients secondary to rheumatoid arthritis. Arthritis Rheum. 2004;50(Suppl):163.
    • (2004) Arthritis Rheum. , vol.50 , Issue.SUPPL. , pp. 163
    • Nakamura, T.1    Tsukano, M.2    Tomoda, K.3    Yamamura, Y.4    Shono, M.5    Baba, S.6
  • 36
    • 34548312539 scopus 로고    scopus 로고
    • Novel polymorphisms in the 5′-flanking region of the human serum amyloid A1 (SAA1) gene and an association with reactive AA-amyloidosis
    • Baba S, Nakai H, Nakamura T, Miyamoto S, Ohta Y, Takahashi T, et al. Novel polymorphisms in the 5′-flanking region of the human serum amyloid A1 (SAA1) gene and an association with reactive AA-amyloidosis. Amyloid. 2001;8(Suppl 2):41-3.
    • (2001) Amyloid , vol.8 , Issue.SUPPL. 2 , pp. 41-43
    • Baba, S.1    Nakai, H.2    Nakamura, T.3    Miyamoto, S.4    Ohta, Y.5    Takahashi, T.6
  • 37
    • 29844441293 scopus 로고    scopus 로고
    • Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis
    • Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology. 2006;45:43-9.
    • (2006) Rheumatology , vol.45 , pp. 43-49
    • Nakamura, T.1    Higashi, S.2    Tomoda, K.3    Tsukano, M.4    Baba, S.5    Shono, M.6
  • 38
    • 0023223933 scopus 로고
    • Secondary amyloidosis of the bladder: A cause of massive hematuria
    • Nurumi MJ, Ekfors TO, Puntala PV. Secondary amyloidosis of the bladder: a cause of massive hematuria. J Urol. 1987;138:44-5.
    • (1987) J Urol. , vol.138 , pp. 44-45
    • Nurumi, M.J.1    Ekfors, T.O.2    Puntala, P.V.3
  • 39
    • 0141884210 scopus 로고    scopus 로고
    • Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: Three case reports
    • Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Baba S. Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: Three case reports. Clin Exp Rheumatol. 2003;21:673-4.
    • (2003) Clin Exp Rheumatol. , vol.21 , pp. 673-674
    • Nakamura, T.1    Yamamura, Y.2    Tomoda, K.3    Tsukano, M.4    Baba, S.5
  • 40
    • 0035147048 scopus 로고    scopus 로고
    • The clinical significance of amyloid fat deposit in rheumatoid arthritis. A systemic long-term followup study using abdominal fat aspiration
    • Gomez-Casanovas E, Sanmarti R, Sole M, Canate JD, Munoz-Gomez J. The clinical significance of amyloid fat deposit in rheumatoid arthritis. A systemic long-term followup study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66-72.
    • (2001) Arthritis Rheum. , vol.44 , pp. 66-72
    • Gomez-Casanovas, E.1    Sanmarti, R.2    Sole, M.3    Canate, J.D.4    Munoz-Gomez, J.5
  • 42
    • 0141892843 scopus 로고    scopus 로고
    • Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis
    • Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:800-5.
    • (2003) Intern Med. , vol.42 , pp. 800-805
    • Ishii, W.1    Matsuda, M.2    Nakamura, A.3    Nakamura, N.4    Suzuki, A.5    Ikeda, S.6
  • 43
    • 0038076261 scopus 로고    scopus 로고
    • Prevalence of secondary amyloidosis in Asian north Indian patients with rheumatoid arthritis
    • Wakhlu A, Krisnani N, Hissatia P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian north Indian patients with rheumatoid arthritis. J Rheumatol. 2003;30:948-51.
    • (2003) J Rheumatol. , vol.30 , pp. 948-951
    • Wakhlu, A.1    Krisnani, N.2    Hissatia, P.3    Aggarwal, A.4    Misra, R.5
  • 44
    • 0036147031 scopus 로고    scopus 로고
    • Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: Clinical and laboratory characteristics
    • El Mansoury TM, Hazenberg BP, El Badawy SA, Ahmed AH, Bijzet J, Limburg PC, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: Clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42-7.
    • (2002) Ann Rheum Dis. , vol.61 , pp. 42-47
    • El Mansoury, T.M.1    Hazenberg, B.P.2    El Badawy, S.A.3    Ahmed, A.H.4    Bijzet, J.5    Limburg, P.C.6
  • 45
    • 1542681892 scopus 로고    scopus 로고
    • Secondary amyloidosis in patients with rheumatoid arthritis: Diagnostic and prognostic value of gastroduodenal biopsy
    • Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Miyamoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol. 1996;35:44-9.
    • (1996) Br J Rheumatol. , vol.35 , pp. 44-49
    • Kobayashi, H.1    Tada, S.2    Fuchigami, T.3    Okuda, Y.4    Takasugi, K.5    Miyamoto, T.6
  • 46
    • 0042887249 scopus 로고    scopus 로고
    • Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity
    • Carmona L, Gonzalez-Alvaro I, Balsa A, Belmonte MA, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62:897-900.
    • (2003) Ann Rheum Dis. , vol.62 , pp. 897-900
    • Carmona, L.1    Gonzalez-Alvaro, I.2    Balsa, A.3    Belmonte, M.A.4    Tena, X.5    Sanmarti, R.6
  • 47
    • 0037385944 scopus 로고    scopus 로고
    • Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis
    • Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol. 2003;30:697-704.
    • (2003) J Rheumatol. , vol.30 , pp. 697-704
    • Gonzalez-Alvaro, I.1    Carmona, L.2    Balsa, A.3    Sanmarti, R.4    Belmonte, M.A.5    Tena, X.6
  • 48
    • 34548297952 scopus 로고    scopus 로고
    • Prevalence of silent amyloidosis in rheumatoid arthritis and its clinical significance
    • Misra R, Wakhlu A, Krishnani N, Hissaaria P, Aggarwal A. Prevalence of silent amyloidosis in rheumatoid arthritis and its clinical significance. J Rheumatol. 2004;31:1031-4.
    • (2004) J Rheumatol. , vol.31 , pp. 1031-1034
    • Misra, R.1    Wakhlu, A.2    Krishnani, N.3    Hissaaria, P.4    Aggarwal, A.5
  • 49
    • 0033895284 scopus 로고    scopus 로고
    • Presentation, survival and prognostic markers in AA amyloidosis
    • Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Q J Med. 2000;93:535-42.
    • (2000) Q J Med. , vol.93 , pp. 535-542
    • Joss, N.1    McLaughlin, K.2    Simpson, K.3    Boulton-Jones, J.M.4
  • 52
    • 0035822274 scopus 로고    scopus 로고
    • Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
    • Gillmore JO, Levitt LB, Jersey MA, PepysMB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24-9.
    • (2001) Lancet , vol.358 , pp. 24-29
    • Gillmore, J.O.1    Levitt, L.B.2    Jersey, M.A.3    Pepys, M.B.4    Hawkins, P.N.5
  • 53
    • 41849122335 scopus 로고    scopus 로고
    • Female is a risk factor for developing AA-amyloidosis in patients with rheumatoid arthritis
    • Kitahama M, Koseki Y, Sakurai T, Kamatani N, Terai C. Female is a risk factor for developing AA-amyloidosis in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56(Suppl):410-1.
    • (2007) Arthritis Rheum. , vol.56 , Issue.SUPPL. , pp. 410-411
    • Kitahama, M.1    Koseki, Y.2    Sakurai, T.3    Kamatani, N.4    Terai, C.5
  • 54
    • 0022870564 scopus 로고
    • Severe autonomic neuropathy in amyloidosis secondary to rheumatoid arthritis
    • McGill NW, Tuck R, Hassall JE. Severe autonomic neuropathy in amyloidosis secondary to rheumatoid arthritis. Aust N Z J Med. 1986;16:705-7.
    • (1986) Aust N Z J Med. , vol.16 , pp. 705-707
    • McGill, N.W.1    Tuck, R.2    Hassall, J.E.3
  • 55
    • 11144316233 scopus 로고    scopus 로고
    • Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis
    • Nakamura T, Tomoda K, Tsukano M, Yamamura Y, Baba S. Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol. 2004;14:498-501.
    • (2004) Mod Rheumatol. , vol.14 , pp. 498-501
    • Nakamura, T.1    Tomoda, K.2    Tsukano, M.3    Yamamura, Y.4    Baba, S.5
  • 56
    • 0344406267 scopus 로고    scopus 로고
    • Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy
    • Mpofu S, Teh LS, Smith PJ, Moots RJ, Hawkins PN. Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology. 2003;42:362-6.
    • (2003) Rheumatology , vol.42 , pp. 362-366
    • Mpofu, S.1    Teh, L.S.2    Smith, P.J.3    Moots, R.J.4    Hawkins, P.N.5
  • 57
    • 0036166309 scopus 로고    scopus 로고
    • How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis
    • Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW. How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46:357-65.
    • (2002) Arthritis Rheum. , vol.46 , pp. 357-365
    • Visser, H.1    le Cessie, S.2    Vos, K.3    Breedveld, F.C.4    Hazes, J.M.W.5
  • 59
    • 0038174742 scopus 로고    scopus 로고
    • Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis
    • Ishii W, Matsuda M, Nakamura N, Katsumata S, Toriumi H, Suzuki A, et al. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:400-5.
    • (2003) Intern Med. , vol.42 , pp. 400-405
    • Ishii, W.1    Matsuda, M.2    Nakamura, N.3    Katsumata, S.4    Toriumi, H.5    Suzuki, A.6
  • 60
    • 11144354315 scopus 로고    scopus 로고
    • Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate
    • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum. 2004;50:1051-65.
    • (2004) Arthritis Rheum. , vol.50 , pp. 1051-1065
    • Maini, R.N.1    Breedveld, F.C.2    Kalden, J.R.3    Smolen, J.S.4    Furst, D.5    Weisman, M.H.6
  • 61
    • 0142093231 scopus 로고    scopus 로고
    • Window of opportunity in early rheumatoid arthritis: Possibility of altering the disease process with early intervention
    • Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol. 2003;21(Suppl 31):154-64.
    • (2003) Clin Exp Rheumatol. , vol.21 , Issue.SUPPL. 31 , pp. 154-164
    • Quinn, M.A.1    Emery, P.2
  • 62
    • 0023597242 scopus 로고
    • Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency
    • Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol. 1987;6:27-38.
    • (1987) Clin Rheumatol. , vol.6 , pp. 27-38
    • Ahlmen, M.1    Ahlmen, J.2    Svalander, C.3    Bucht, H.4
  • 63
    • 0027715981 scopus 로고
    • Results, principles and pitfalls in the management of renal AA-amyloidosis: A 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics
    • Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis: A 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol. 1993;20:2051-7.
    • (1993) J Rheumatol. , vol.20 , pp. 2051-2057
    • Berglund, K.1    Thysell, H.2    Keller, C.3
  • 64
    • 0034894409 scopus 로고    scopus 로고
    • Renal type AA amyloidosis associated with rheumatoid arthritis: A cohort study showing improved survival on treatment with pulse cyclophosphamide
    • Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: A cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology. 2001;40:821-5.
    • (2001) Rheumatology , vol.40 , pp. 821-825
    • Chevrel, G.1    Jenvrin, C.2    McGregor, B.3    Miossec, P.4
  • 65
    • 0029591203 scopus 로고
    • Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report
    • Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum. 1995;38:1851-4.
    • (1995) Arthritis Rheum. , vol.38 , pp. 1851-1854
    • Shapiro, D.L.1    Spiera, H.2
  • 66
    • 0029037389 scopus 로고
    • Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis
    • Fiter J, Nolla JM, Valverde J, Roig ED. Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis. Rev Clin Esp. 1995;195:390-2.
    • (1995) Rev Clin Esp. , vol.195 , pp. 390-392
    • Fiter, J.1    Nolla, J.M.2    Valverde, J.3    Roig, E.D.4
  • 67
    • 2342511644 scopus 로고    scopus 로고
    • Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis
    • Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol. 2003;22:371-5.
    • (2003) Clin Rheumatol. , vol.22 , pp. 371-375
    • Nakamura, T.1    Yamamura, Y.2    Tomoda, K.3    Tsukano, M.4    Shono, M.5    Baba, S.6
  • 69
    • 41849110594 scopus 로고    scopus 로고
    • Treatment with eprodisate results in a significant delay in the progression to dialysis/end-stage renal disease in amyloid A amyloidosis patients: Analysis including retrieved follow-up data
    • Gorevic PD, Hawkins PN, Skinner M, Nasonov EL, Butrimiene I, Benson MD, et al. Treatment with eprodisate results in a significant delay in the progression to dialysis/end-stage renal disease in amyloid A amyloidosis patients: Analysis including retrieved follow-up data. Arthritis Rheum. 2007;56(Suppl):520.
    • (2007) Arthritis Rheum. , vol.56 , Issue.SUPPL. , pp. 520
    • Gorevic, P.D.1    Hawkins, P.N.2    Skinner, M.3    Nasonov, E.L.4    Butrimiene, I.5    Benson, M.D.6
  • 71
    • 10744223002 scopus 로고    scopus 로고
    • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial
    • Klareskog L, van der Heiji D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomized controlled trial. Lancet. 2004;363:675-81.
    • (2004) Lancet , vol.363 , pp. 675-681
    • Klareskog, L.1    van der Heiji, D.2    de Jager, J.P.3    Gough, A.4    Kalden, J.5    Malaise, M.6
  • 72
    • 8344222831 scopus 로고    scopus 로고
    • Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis
    • Smith GR, Tymmus KE, Falk M. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis. Intern Med J. 2004;34:570-2.
    • (2004) Intern Med J. , vol.34 , pp. 570-572
    • Smith, G.R.1    Tymmus, K.E.2    Falk, M.3
  • 73
    • 0036822905 scopus 로고    scopus 로고
    • Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab
    • Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002;46:2571-3.
    • (2002) Arthritis Rheum. , vol.46 , pp. 2571-5273
    • Elkayam, O.1    Hawkins, P.N.2    Lachmann, H.3    Yaron, M.4    Caspi, D.5
  • 75
    • 0037666987 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides. A followup report of tolerability and efficacy
    • Gottenberg J-E, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, et al. Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides. A followup report of tolerability and efficacy. Arthritis Rheum. 2003;48:2019-24.
    • (2003) Arthritis Rheum. , vol.48 , pp. 2019-2024
    • Gottenberg, J.-E.1    Merle-Vincent, F.2    Bentaberry, F.3    Allanore, Y.4    Berenbaum, F.5    Fautrel, B.6
  • 76
    • 2442432420 scopus 로고    scopus 로고
    • Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade
    • Ravindran J, Shenker N, Bhalla AK, Lachmann H, Hawkins P. Case report: response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade. Rheumatology. 2004;43:669-72.
    • (2004) Rheumatology , vol.43 , pp. 669-672
    • Ravindran, J.1    Shenker, N.2    Bhalla, A.K.3    Lachmann, H.4    Hawkins, P.5
  • 77
    • 20944451093 scopus 로고    scopus 로고
    • Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
    • Fernandes-Nebro A, Tomero E, Ortiz-Santamaria V, Castro MC, Olive A, de Haro M, et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med. 2005;118:552-6.
    • (2005) Am J Med. , vol.118 , pp. 552-556
    • Fernandes-Nebro, A.1    Tomero, E.2    Ortiz-Santamaria, V.3    Castro, M.C.4    Olive, A.5    de Haro, M.6
  • 78
    • 33749331603 scopus 로고    scopus 로고
    • Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizmab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
    • Okuda Y, Takasugi K. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizmab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum. 2006;54:2997-3000.
    • (2006) Arthritis Rheum. , vol.54 , pp. 2997-3000
    • Okuda, Y.1    Takasugi, K.2
  • 79
    • 34648846150 scopus 로고    scopus 로고
    • Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis
    • Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:518-22.
    • (2007) Clin Exp Rheumatol. , vol.25 , pp. 518-522
    • Nakamura, T.1    Higashi, S.2    Tomoda, K.3    Tsukano, M.4    Baba, S.5
  • 80
    • 0033819386 scopus 로고    scopus 로고
    • Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis
    • Jeong Y-S, Jun J-B, Kim T-H, Lee I-H, Bae S-C, Yoo D-H, et al. Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis. Clin Exp Rheumatol. 2000;18:619-21.
    • (2000) Clin Exp Rheumatol. , vol.18 , pp. 619-621
    • Jeong, Y.-S.1    Jun, J.-B.2    Kim, T.-H.3    Lee, I.-H.4    Bae, S.-C.5    Yoo, D.-H.6
  • 81
    • 21244476771 scopus 로고    scopus 로고
    • Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide
    • Fushimi T, Takahashi Y, Kashima Y, Fukushima K, Ishii W, Kaneko K, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid. 2005;12:48-53.
    • (2005) Amyloid , vol.12 , pp. 48-53
    • Fushimi, T.1    Takahashi, Y.2    Kashima, Y.3    Fukushima, K.4    Ishii, W.5    Kaneko, K.6
  • 82
    • 0032960338 scopus 로고    scopus 로고
    • Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland
    • Laiho K, Tiitinen S, Kaarela K, Helin H, Isomaki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol. 1999;18:122-3.
    • (1999) Clin Rheumatol. , vol.18 , pp. 122-123
    • Laiho, K.1    Tiitinen, S.2    Kaarela, K.3    Helin, H.4    Isomaki, H.5
  • 85
    • 0036169930 scopus 로고    scopus 로고
    • Guidelines for the management of rheumatoid arthritis: 2002 Update
    • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
    • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002;46:328-46.
    • (2002) Arthritis Rheum. , vol.46 , pp. 328-346
  • 86
    • 0345299157 scopus 로고
    • Amyloid protein SAA is associated with high density lipoprotein from human serum
    • Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci (USA) 1977;74:4025-8.
    • (1977) Proc Natl Acad Sci (USA) , vol.74 , pp. 4025-4028
    • Benditt, E.P.1    Eriksen, N.2
  • 88
    • 0034687430 scopus 로고    scopus 로고
    • Inflammatory markers of coronary risk
    • Rader DJ. Inflammatory markers of coronary risk. N Engl J Med. 2000;343:1179-82.
    • (2000) N Engl J Med. , vol.343 , pp. 1179-1182
    • Rader, D.J.1
  • 89
    • 33646417915 scopus 로고    scopus 로고
    • Serum amyloid A. The "other" inflammatory protein
    • O'Brein KD, Chait A. Serum amyloid A. The "other" inflammatory protein. Curr Atheroscler Rep. 2006;8:62-8.
    • (2006) Curr Atheroscler Rep. , vol.8 , pp. 62-68
    • O'Brein, K.D.1    Chait, A.2
  • 90
    • 34250872848 scopus 로고    scopus 로고
    • Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells
    • Zhao Y, Zhou S, Heng C-K. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Thromb Vasc Biol. 2007;27:1645-50.
    • (2007) Thromb Vasc Biol. , vol.27 , pp. 1645-1650
    • Zhao, Y.1    Zhou, S.2    Heng, C.-K.3
  • 91
    • 34250197588 scopus 로고    scopus 로고
    • Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties
    • Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, et al. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol. 2007;34:1293-301.
    • (2007) J Rheumatol. , vol.34 , pp. 1293-1301
    • Bokarewa, M.1    Abrahamson, M.2    Levshin, N.3    Egesten, A.4    Grubb, A.5    Dahlberg, L.6
  • 92
    • 33749529307 scopus 로고    scopus 로고
    • Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis
    • Lee M-S, Yoo S-A, Cho C-S, Suh P-G, Kim W-U, Ryu SH. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol. 2006;177:5585-94.
    • (2006) J Immunol. , vol.177 , pp. 5585-5594
    • Lee, M.-S.1    Yoo, S.-A.2    Cho, C.-S.3    Suh, P.-G.4    Kim, W.-U.5    Ryu, S.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.